Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (107 total)
-
Créateur: Normand, Sharon-Lise T.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-21
Description: In a platform trial, patients with a single disease are randomly assigned to a group of different therapies on the basis of a decision algorithm to determine whether any therapy has benefit. -
Créateur: Connor, M. J., Jr., C. Kraft, A. K. Mehta, J. B. Varkey, G. M. Lyon, I. Crozier, U. Stroher, B. S. Ribner and H. A. Franch
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2015-01-01
Description: AKI has been observed in cases of Ebola virus disease.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: NIH
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2020-02-10
Description: In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (2019-nCoV) from these pneumonia patients… -
Créateur: Tapia, Milagritos D., Samba O. Sow, Khardiata D. Mbaye, Aliou Thiongane, Birahim P. Ndiaye, Cheikh T. Ndour, Souleymane Mboup, Babajide Keshinro, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku P. Asante,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-19
Description: During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus, about 20% of cases were reported in children. This study is the first, to our knowledge, to evaluate an Ebola vaccine in children younger than 6 years. -
Créateur: Tapia, Milagritos D., Samba O. Sow, Birahim P. Ndiaye, Khardiata D. Mbaye, Aliou Thiongane, Cheikh T. Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Gideon A. Akintunde, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-19
Description: The 2014 Zaire Ebola virus disease epidemic accelerated vaccine development for the virus. -
Créateur: Isakov, A., A. Jamison, W. Miles and B. Ribner
Sujet: Pre-Hospital
Type d'élément: Publication
Date de la dernière mise à jour: 2014-12-02
Description: Health care workers (HCWs) in the emergency medical services (EMS) and hospital settings often encounter patients infected with dangerous communicable diseases. -
Créateur: National Institute of Allergy and Infectious Diseases [National Institutes of Health] NIH (NIAID)
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-04
Description: The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and… -
Créateur: WHO Solidarity Trial Consortium
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-02
Description: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). -
Créateur: the ACTT-1 Study Group Members
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2020-05-22
Description: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement." -
Créateur: the ACTT-1 Study Group Members
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.A response to this article was published:Dolin, Raphael,…